ID29966A - Sulfoniloksazolamina-sulfoniloksazolamina sebagai senyawa-senyawa aktif terapi - Google Patents
Sulfoniloksazolamina-sulfoniloksazolamina sebagai senyawa-senyawa aktif terapiInfo
- Publication number
- ID29966A ID29966A IDW00200101555A ID20011555A ID29966A ID 29966 A ID29966 A ID 29966A ID W00200101555 A IDW00200101555 A ID W00200101555A ID 20011555 A ID20011555 A ID 20011555A ID 29966 A ID29966 A ID 29966A
- Authority
- ID
- Indonesia
- Prior art keywords
- sulfonyloksazolamina
- therapy
- active compounds
- compounds
- active
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/48—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19858593A DE19858593A1 (de) | 1998-12-18 | 1998-12-18 | Sulfonyloxazolamine als therapeutische Wirkstoffe |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID29966A true ID29966A (id) | 2001-10-25 |
Family
ID=7891645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW00200101555A ID29966A (id) | 1998-12-18 | 1999-12-01 | Sulfoniloksazolamina-sulfoniloksazolamina sebagai senyawa-senyawa aktif terapi |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6441013B1 (id) |
| EP (1) | EP1140875A1 (id) |
| JP (1) | JP2002533332A (id) |
| CN (1) | CN1146549C (id) |
| AR (1) | AR021896A1 (id) |
| AU (1) | AU763070B2 (id) |
| BR (1) | BR9916310A (id) |
| CA (1) | CA2356134A1 (id) |
| CZ (1) | CZ20012144A3 (id) |
| DE (1) | DE19858593A1 (id) |
| HK (1) | HK1043125A1 (id) |
| HU (1) | HUP0104834A3 (id) |
| ID (1) | ID29966A (id) |
| NO (1) | NO20012965D0 (id) |
| PL (1) | PL349393A1 (id) |
| RU (1) | RU2232757C2 (id) |
| SK (1) | SK8132001A3 (id) |
| WO (1) | WO2000037452A1 (id) |
| ZA (1) | ZA200105881B (id) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19956791A1 (de) | 1999-11-25 | 2001-05-31 | Merck Patent Gmbh | Neue Sulfonyloxazolamine |
| DE10129940A1 (de) * | 2001-06-13 | 2002-12-19 | Merck Patent Gmbh | Sulfonyloxazolamine als therapeutische Wirkstoffe |
| US6875771B2 (en) | 2002-07-26 | 2005-04-05 | Bristol-Myers Squibb Company | Pyridopyrimidine derivatives as 5-HT6 antagonists |
| FR2854632B1 (fr) * | 2003-05-07 | 2005-06-17 | Centre Nat Rech Scient | Synthese de composes heterocycliques substitues |
| GB0419192D0 (en) * | 2004-08-27 | 2004-09-29 | Merck Sharp & Dohme | Therapeutic agents |
| HRP20100181T1 (hr) * | 2004-12-21 | 2010-05-31 | F. Hoffmann - La Roche Ag | Derivati tetralina i indana i njihove upotrebe |
| AU2006278998A1 (en) * | 2005-07-29 | 2007-02-15 | 4Sc Ag | Novel heterocyclic NF-kB inhibitors |
| DE102005061429A1 (de) * | 2005-12-22 | 2007-06-28 | Grünenthal GmbH | Substituierte Oxazol-Derivate |
| WO2008061248A2 (en) * | 2006-11-16 | 2008-05-22 | The Regents Of The University Of California | Phenylsulfoxyoxazole compound inhibitors of urea transporters |
| JP5248528B2 (ja) * | 2007-02-02 | 2013-07-31 | エフ．ホフマン−ラ ロシュ アーゲー | Ｃｎｓ疾患用のｔａａｒ１リガンドとしての新規２−アミノオキサゾリン |
| MX2009008465A (es) * | 2007-02-15 | 2009-08-20 | Hoffmann La Roche | Nuevas 2-aminooxazolinas como ligandos de taar1. |
| EP2520437B1 (en) | 2009-12-28 | 2015-05-20 | Brother Kogyo Kabushiki Kaisha | Tape cassette |
| RU2443697C1 (ru) | 2010-12-21 | 2012-02-27 | Александр Васильевич Иващенко | Замещенные метил-амины, антагонисты серотониновых 5-ht6 рецепторов, способы получения и применения |
| WO2018012769A1 (ko) * | 2016-07-12 | 2018-01-18 | 연세대학교 산학협력단 | 자가포식 향상물질 및 그 용도 |
| KR102533605B1 (ko) * | 2018-01-10 | 2023-05-17 | 주식회사 라이조테크 | 신규한 페닐설포닐 옥사졸 유도체 및 이의 용도 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996036617A1 (en) * | 1995-05-19 | 1996-11-21 | G.D. Searle & Co. | Substituted oxazoles for the treatment of inflammation |
| AU717230B2 (en) * | 1996-02-20 | 2000-03-23 | Bristol-Myers Squibb Company | Methods for the preparation of biphenyl isoxazole sulfonamides |
-
1998
- 1998-12-18 DE DE19858593A patent/DE19858593A1/de not_active Withdrawn
-
1999
- 1999-12-01 AU AU18612/00A patent/AU763070B2/en not_active Ceased
- 1999-12-01 EP EP99962190A patent/EP1140875A1/de not_active Withdrawn
- 1999-12-01 BR BR9916310-1A patent/BR9916310A/pt not_active IP Right Cessation
- 1999-12-01 US US09/868,097 patent/US6441013B1/en not_active Expired - Fee Related
- 1999-12-01 CA CA002356134A patent/CA2356134A1/en not_active Abandoned
- 1999-12-01 WO PCT/EP1999/009335 patent/WO2000037452A1/de not_active Ceased
- 1999-12-01 JP JP2000589524A patent/JP2002533332A/ja active Pending
- 1999-12-01 HK HK02104944.7A patent/HK1043125A1/zh unknown
- 1999-12-01 RU RU2001119273/04A patent/RU2232757C2/ru not_active IP Right Cessation
- 1999-12-01 PL PL99349393A patent/PL349393A1/xx unknown
- 1999-12-01 ID IDW00200101555A patent/ID29966A/id unknown
- 1999-12-01 CN CNB998147281A patent/CN1146549C/zh not_active Expired - Fee Related
- 1999-12-01 CZ CZ20012144A patent/CZ20012144A3/cs unknown
- 1999-12-01 SK SK813-2001A patent/SK8132001A3/sk unknown
- 1999-12-01 HU HU0104834A patent/HUP0104834A3/hu unknown
- 1999-12-17 AR ARP990106528A patent/AR021896A1/es not_active Application Discontinuation
-
2001
- 2001-06-15 NO NO20012965A patent/NO20012965D0/no not_active Application Discontinuation
- 2001-07-17 ZA ZA200105881A patent/ZA200105881B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2356134A1 (en) | 2000-06-29 |
| WO2000037452A1 (de) | 2000-06-29 |
| NO20012965L (no) | 2001-06-15 |
| BR9916310A (pt) | 2001-11-06 |
| CZ20012144A3 (cs) | 2002-01-16 |
| AU1861200A (en) | 2000-07-12 |
| HUP0104834A2 (hu) | 2002-07-29 |
| RU2232757C2 (ru) | 2004-07-20 |
| CN1331684A (zh) | 2002-01-16 |
| PL349393A1 (en) | 2002-07-15 |
| AU763070B2 (en) | 2003-07-10 |
| DE19858593A1 (de) | 2000-06-21 |
| HK1043125A1 (zh) | 2002-09-06 |
| SK8132001A3 (en) | 2002-02-05 |
| AR021896A1 (es) | 2002-08-07 |
| JP2002533332A (ja) | 2002-10-08 |
| HUP0104834A3 (en) | 2005-06-28 |
| NO20012965D0 (no) | 2001-06-15 |
| CN1146549C (zh) | 2004-04-21 |
| US6441013B1 (en) | 2002-08-27 |
| ZA200105881B (en) | 2002-10-17 |
| EP1140875A1 (de) | 2001-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID22878A (id) | Komposisi aktif secara terapi | |
| ID24372A (id) | SENYAWA-SENYAWA 4-AMINO-TIAZOL-2-IL SEBAGAI PENGHAMBAT-PENGHAMBAT CDKs | |
| IS2325B (is) | Örgerðar samsetningar epleróns | |
| DE60024988D1 (de) | Herstellung von therapeutischem mikroschaum | |
| EE200200172A (et) | Ühendid isheemia ravimiseks | |
| ID27841A (id) | Turunan-turunan biaril terapeutik | |
| ID25792A (id) | Antibodi-antibodi terhadap cd40 manusia | |
| ID29021A (id) | Komposisi galantamina pelepasan terkontrol | |
| EE04390B1 (et) | Paikne preparaat dermatoloogiliste seisundite raviks | |
| ID25824A (id) | Formulasi terapeutik untuk memberikan tolterodin dengan pelepasan yang terkendali | |
| PT1220856E (pt) | Compostos farmaceuticamente activos | |
| NO20022692D0 (no) | Terapeutiske midler | |
| ID26861A (id) | Terapi gabungan untuk pengobatan depresi refaktori | |
| ID29966A (id) | Sulfoniloksazolamina-sulfoniloksazolamina sebagai senyawa-senyawa aktif terapi | |
| NO20001847L (no) | Ny anvendelse av forbindelser for anti-kløe-aktivitet | |
| AR028060A1 (es) | Combinaciones de compuestos activos fungicidas | |
| TR199903132A3 (tr) | Metalosan bilesiklerinin aktive edici kompozisyonu. | |
| ID24677A (id) | Kombinasi senyawa aktif fungisidal | |
| ID28032A (id) | TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2 | |
| NO963871D0 (no) | Kombinasjoner av aktive insektisidforbindelser | |
| DE59911707D1 (de) | Fungizide wirkstoffkombinationen | |
| BR9609288A (pt) | Combinações de compostos ativos fungicidas | |
| DE60016608D1 (de) | Herstellung von sulfonylimin-verbindungen | |
| PT1175417E (pt) | Compostos substituidos de benzolactamas | |
| ID24922A (id) | Terapi kombinasi untuk pengobatan aids |